These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 20951036)
21. Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity. Liu J; He S; Jian T; Dobbelaar PH; Sebhat IK; Lin LS; Goodman A; Guo C; Guzzo PR; Hadden M; Henderson AJ; Pattamana K; Ruenz M; Sargent BJ; Swenson B; Yet L; Tamvakopoulos C; Peng Q; Pan J; Kan Y; Palyha O; Kelly TM; Guan XM; Howard AD; Marsh DJ; Metzger JM; Reitman ML; Wyvratt MJ; Nargund RP Bioorg Med Chem Lett; 2010 Apr; 20(7):2074-7. PubMed ID: 20219372 [TBL] [Abstract][Full Text] [Related]
24. Spiroindane based amides as potent and selective MC4R agonists for the treatment of obesity. He S; Ye Z; Dobbelaar PH; Sebhat IK; Guo L; Liu J; Jian T; Lai Y; Franklin CL; Bakshi RK; Dellureficio JP; Hong Q; Weinberg DH; Macneil T; Tang R; Strack AM; Tamvakopoulos C; Peng Q; Miller RR; Stearns RA; Chen HY; Chen AS; Fong TM; Wyvratt MJ; Nargund RP Bioorg Med Chem Lett; 2010 Aug; 20(15):4399-405. PubMed ID: 20598882 [TBL] [Abstract][Full Text] [Related]
25. MCH-R1 Antagonist GPS18169, a Pseudopeptide, Is a Peripheral Anti-Obesity Agent in Mice. Boutin JA; Jullian M; Frankiewicz L; Galibert M; Gloanec P; Le Diguarher T; Dupuis P; Ko A; Ripoll L; Bertrand M; Pecquery A; Ferry G; Puget K Molecules; 2021 Feb; 26(5):. PubMed ID: 33673598 [TBL] [Abstract][Full Text] [Related]
26. Discovery of imidazo[1,2-a]pyridines as potent MCH1R antagonists. Kishino H; Moriya M; Sakuraba S; Sakamoto T; Takahashi H; Suzuki T; Moriya R; Ito M; Iwaasa H; Takenaga N; Ishihara A; Kanatani A; Sato N; Fukami T Bioorg Med Chem Lett; 2009 Aug; 19(16):4589-93. PubMed ID: 19615899 [TBL] [Abstract][Full Text] [Related]
27. Oxadiazole-diarylpyrazole 4-carboxamides as cannabinoid CB1 receptor ligands. Lee SH; Seo HJ; Kim MJ; Kang SY; Song KS; Lee SH; Jung ME; Kim J; Lee J Bioorg Med Chem Lett; 2009 Apr; 19(7):1899-902. PubMed ID: 19269817 [TBL] [Abstract][Full Text] [Related]
28. Benzodioxoles: novel cannabinoid-1 receptor inverse agonists for the treatment of obesity. Alig L; Alsenz J; Andjelkovic M; Bendels S; Bénardeau A; Bleicher K; Bourson A; David-Pierson P; Guba W; Hildbrand S; Kube D; Lübbers T; Mayweg AV; Narquizian R; Neidhart W; Nettekoven M; Plancher JM; Rocha C; Rogers-Evans M; Röver S; Schneider G; Taylor S; Waldmeier P J Med Chem; 2008 Apr; 51(7):2115-27. PubMed ID: 18335976 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and SAR of heterocyclic carboxylic acid isosteres based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity. Hadden M; Goodman A; Guo C; Guzzo PR; Henderson AJ; Pattamana K; Ruenz M; Sargent BJ; Swenson B; Yet L; Liu J; He S; Sebhat IK; Lin LS; Tamvakopoulos C; Peng Q; Kan Y; Palyha O; Kelly TM; Guan XM; Metzger JM; Reitman ML; Nargund RP Bioorg Med Chem Lett; 2010 May; 20(9):2912-5. PubMed ID: 20347296 [TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists. Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332 [TBL] [Abstract][Full Text] [Related]
33. Discovery and characterization of aminopiperidinecoumarin melanin concentrating hormone receptor 1 antagonists. Kym PR; Iyengar R; Souers AJ; Lynch JK; Judd AS; Gao J; Freeman J; Mulhern M; Zhao G; Vasudevan A; Wodka D; Blackburn C; Brown J; Che JL; Cullis C; Lai SJ; LaMarche MJ; Marsilje T; Roses J; Sells T; Geddes B; Govek E; Patane M; Fry D; Dayton BD; Brodjian S; Falls D; Brune M; Bush E; Shapiro R; Knourek-Segel V; Fey T; McDowell C; Reinhart GA; Preusser LC; Marsh K; Hernandez L; Sham HL; Collins CA J Med Chem; 2005 Sep; 48(19):5888-91. PubMed ID: 16161992 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of new arylsulfonamidomethylcyclohexyl derivatives as human neuropeptide Y Y5 receptor antagonists for the treatment of obesity. Moreno A; Pérez S; Galiano S; Juanenea L; Erviti O; Frígola C; Aldana I; Monge A Eur J Med Chem; 2004 Jan; 39(1):49-58. PubMed ID: 14987833 [TBL] [Abstract][Full Text] [Related]
35. Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R). Velaparthi U; Wittman M; Liu P; Stoffan K; Zimmermann K; Sang X; Carboni J; Li A; Attar R; Gottardis M; Greer A; Chang CY; Jacobsen BL; Sack JS; Sun Y; Langley DR; Balasubramanian B; Vyas D Bioorg Med Chem Lett; 2007 Apr; 17(8):2317-21. PubMed ID: 17317169 [TBL] [Abstract][Full Text] [Related]